Total Payments
$2,833
2024 Payments
$98.62
Companies
11
Transactions
33
Payment Breakdown by Category
Food & Beverage$2,833 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,833 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $735.10 | 8 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $642.20 | 8 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $424.07 | 4 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $191.36 | 2 | $0 (2024) |
| Alkermes, Inc. | $190.11 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $165.93 | 3 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
| Allergan Inc. | $91.78 | 1 | $0 (2019) |
| ITI, Inc. | $85.34 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.62 | 1 | Teva Pharmaceuticals USA, Inc. ($98.62) |
| 2023 | $174.23 | 2 | Neurocrine Biosciences, Inc. ($174.23) |
| 2022 | $517.49 | 6 | Neurocrine Biosciences, Inc. ($290.07) |
| 2021 | $267.42 | 3 | Neurocrine Biosciences, Inc. ($93.90) |
| 2019 | $443.24 | 6 | Sunovion Pharmaceuticals Inc. ($132.50) |
| 2018 | $855.69 | 8 | Otsuka America Pharmaceutical, Inc. ($225.60) |
| 2017 | $476.54 | 7 | Sunovion Pharmaceuticals Inc. ($203.40) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/21/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $98.62 | General |
| Category: Neurology | ||||||
| 09/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $77.21 | General |
| Category: Neuropsychiatry | ||||||
| 05/10/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $97.02 | General |
| Category: Neuropsychiatry | ||||||
| 09/20/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $85.49 | General |
| Category: Neuropsychiatry | ||||||
| 07/22/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Rare Disease | ||||||
| 06/22/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $85.34 | General |
| Category: PSYCHIATRY | ||||||
| 06/17/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 05/04/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $114.20 | General |
| Category: Neuropsychiatry | ||||||
| 01/11/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $90.38 | General |
| Category: Neuropsychiatry | ||||||
| 12/07/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $89.71 | General |
| Category: CNS | ||||||
| 08/25/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $93.90 | General |
| Category: NEUROLOGY | ||||||
| 07/27/2021 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $83.81 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $95.90 | General |
| Category: CNS | ||||||
| 09/17/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $91.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $36.60 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $87.66 | General |
| Category: NEUROLOGY | ||||||
| 04/30/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $100.40 | General |
| Category: CNS | ||||||
| 11/29/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $105.95 | General |
| Category: CNS | ||||||
| 11/08/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $120.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $89.24 | General |
| Category: NEUROLOGY | ||||||
| 09/13/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 07/18/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $100.62 | General |
| Category: Neuroscience | ||||||
| 05/23/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $116.54 | General |
| Category: CNS | ||||||
| 04/18/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $104.80 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Marshall Spencer, M.D
Dr. Marshall Spencer, M.D is a Cardiovascular Disease healthcare provider based in Midland, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609921048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marshall Spencer, M.D has received a total of $2,833 in payments from pharmaceutical and medical device companies, with $98.62 received in 2024. These payments were reported across 33 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,833).
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Midland, MI
- Active Since 01/24/2007
- Last Updated 02/18/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609921048
Products in Payments
- INGREZZA (Drug) $735.10
- LATUDA (Drug) $504.09
- REXULTI (Drug) $303.27
- NUEDEXTA (Drug) $125.00
- ULTOMIRIS (Biological) $125.00
- ABILIFY MAINTENA (Drug) $120.80
- LONHALA MAGNAIR (Drug) $120.41
- INVEGA SUSTENNA (Drug) $100.62
- ARISTADA (Drug) $100.40
- UZEDY (Drug) $98.62
- AUSTEDO (Drug) $92.74
- VRAYLAR (Drug) $91.78
- LYBALVI (Drug) $89.71
- CAPLYTA (Drug) $85.34
- Tresiba (Drug) $40.26
- XARELTO (Drug) $34.41
- INVOKANA (Drug) $30.90
- APTIOM (Drug) $17.70
- Rybelsus (Drug) $17.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Midland
James Barnett, Md, MD
Cardiovascular Disease — Payments: $54,351
Cardiovascular Disease $54,351
Michael Dunleavy, Md, MD
Cardiovascular Disease — Payments: $34,617
Cardiovascular Disease $34,617
Dr. Mark Davis
Cardiovascular Disease — Payments: $9,807
Cardiovascular Disease $9,807
Pankaj Patel, M.d, M.D
Cardiovascular Disease — Payments: $6,864
Cardiovascular Disease $6,864
Stephen Mattichak, Md, MD
Cardiovascular Disease — Payments: $6,801
Cardiovascular Disease $6,801
Michael Miller, Md, MD
Cardiovascular Disease — Payments: $5,989
Cardiovascular Disease $5,989